Biogen reported $570.9M in Cost of Sales for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US USD 4.17B 57M
Acadia Pharmaceuticals ACAD:US USD 2.41M 277K
Acorda Therapeutics ACOR:US USD 4.56M 6.44M
Amgen AMGN:US USD 1.75B 159M
Bayer BAYN:GR EUR 4.77B 521M
Biogen BIIB:US USD 570.9M 101.4M
Biomarin Pharmaceutical BMRN:US USD 127.29M 11M
Bristol Myers Squibb BMY:US USD 2.52B 167M
Eli Lilly And LLY:US USD 1.55B 31M
Esperion Therapeutics ESPR:US USD 4.16M 2.35M
Gilead Sciences GILD:US USD 1.4B 1000K
Intercept Pharmaceuticals ICPT:US USD 28K 396K
Intra Cellular Therapies ITCI:US USD 6.79M 938K
Marinus Pharmaceuticals MRNS:US USD 292K 244K
Merk MRK:US USD 3.36B 519M
Moderna Inc MRNA:US USD 1.92B 818M
Neurocrine Biosciences NBIX:US USD 7.7M 1.6M
Novartis NOVN:VX USD 3.84B 180M
Pfizer PFE:US USD 9.82B 3.73B
Ptc Therapeutics PTCT:US USD 10.89M 3.12M
Puma Biotechnology PBYI:US USD 16.84M 4.34M
Regeneron Pharmaceuticals REGN:US USD 540.6M 222.8M
Sarepta Therapeutics SRPT:US USD 30.8M 9.15M
Seattle Genetics SGEN:US USD 108.21M 88K
Teva Pharmaceutical TEVA:IT USD 1.78B 101M
Ultragenyx Pharmaceutical RARE:US USD 5.32M 3.31M
United Therapeutics UTHR:US USD 58.8M 21.6M
Vertex Pharmaceuticals VRTX:US USD 283.3M 6.1M
YTE INCY:US USD 53.76M 4.48M